Lv12
30 积分 2024-03-05 加入
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
13小时前
已完结
Reappraisal of biologic efficacy from phase 3 trials in refractory chronic rhinosinusitis and nasal polyps
14小时前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
2个月前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
2个月前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
2个月前
已完结
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
2个月前
已完结
New Concepts in Barrier Dysfunction in CRSwNP and Emerging Roles of Tezepelumab and Dupilumab
2个月前
已完结
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study
3个月前
已完结
Targeting HER3 to overcome EGFR TKI resistance in NSCLC
3个月前
已完结
Epidermal growth factor receptor: Role in human cancer
3个月前
已完结
皖公网安备34019202002308
